Category: Intestine and Lower Gastrointestinal Tract

Cytotoxic lymphocyte-to-monocyte ratio predicts colorectal cancer recurrence

A predictive model for recurrence-free survival in colorectal carcinoma was identified through analysis of immune cell populations. Specifically, a lower ratio of cytotoxic lymphocyte to monocytic lineage cells correlated with increased cancer recurrence, outperforming traditional microsatellite status. Gene expression analysis revealed that certain macrophage-related genes were overexpressed in recurrent cases, indicating a protumoral environment. These […]

Elevated calprotectin levels predict early anastomotic leakage outcomes

Findings indicate that increased calprotectin levels in drain fluid post colorectal surgery serve as reliable predictors of early anastomotic leakage (AL). In a cohort of 306 patients, those developing AL exhibited significantly higher calprotectin levels starting from the third postoperative day. Specifically, levels exceeding 110 ng/ml demonstrated 92% sensitivity and 82% specificity for detecting preclinical […]

High Allostatic Load Linked to Serious Surgery Risks in CRC Patients

High allostatic load (AL) significantly correlates with increased risks of complications in colorectal cancer (CRC) surgeries. Among over 40,000 patients, those with high AL had a 48% greater likelihood of postoperative complications, a 79% increased chance of prolonged hospital stays, and doubled mortality risk within 30 days post-surgery. The study emphasizes that CRC patients from […]

Ileocecal resection enhances microbial health in Crohn’s disease.

A multi-omics analysis of ileal mucosa and mesentery samples from Crohn’s disease patients illustrates notable improvements in microbial health following ileocecal resection. Among 34 patients studied, significant spatial changes in microbiota and metabolites were identified pre- and post-surgery. Metabolites were further analyzed, revealing crucial insights into their roles. These findings underscore ileocecal resection as a […]

Size cut-offs established for rectal neuroendocrine neoplasm recurrence

A recent retrospective study involving 1,011 patients identified critical size thresholds for rectal neuroendocrine neoplasms (NENs). For grade 1 tumors, a 0.7 cm cut-off showed 100% sensitivity and 79% specificity, indicating minimal recurrence risk. Conversely, grade 1 tumors with lymphovascular invasion necessitated a 1.5 cm cut-off. Grade 2 NENs, which exhibited a 22.9% lymph node […]

Sarcopenia predicts postoperative complications in colorectal cancer surgery

In a study of 387 patients undergoing laparoscopic radical resection for non-metastatic colorectal cancer, 40.31% were identified as sarcopenic. The overall postoperative complication rate reached 32.3%, with serious complications occurring in 12.1% of patients. Sarcopenic patients experienced significantly higher rates of total complications and serious issues, including anastomotic leakage and surgical site infections. Notably, sarcopenia […]

Neoadjuvant chemotherapy enhances survival rates in colon cancer

Neoadjuvant chemotherapy (NAC) has demonstrated improved five-year overall survival (81.4% versus 77.8%) and disease-free survival (79.2% versus 73.7%) in patients with locally advanced colon cancer compared to upfront surgery followed by adjuvant chemotherapy. Researchers analyzed eight randomized controlled trials involving 3,038 patients, finding NAC to result in better surgical margin outcomes without increasing surgical risks. […]

Apixaban reduces VTE rates compared to enoxaparin in surgery

A study investigating postoperative venous thromboembolism (VTE) prophylaxis in colorectal surgery found that patients receiving apixaban had significantly lower rates of VTE (0.16%) compared to those on enoxaparin (1.29%), with a p-value of 0.023. Despite differences in patient demographics, such as age and operative complexity, the rates of postoperative bleeding were similar between both groups. […]

Endoscopic techniques improve outcomes for rectal precancerous lesions.

Innovative endoscopic procedures, including endoscopic submucosal dissection (ESD) and full-thickness resection, significantly enhance treatment for widespread precancerous lesions and early rectal cancers. ESD achieves over 90% R0 resection rates and offers a low recurrence risk of 3%. Notably, lesions up to 20 cm can be resected in one piece. These advancements allow thorough histopathologic analysis, […]

Endoscopist performance outweighs high-risk polyps in colorectal cancer risk

The study reveals that the risk of post-colonoscopy colorectal cancer (PCCRC) primarily hinges on endoscopist performance rather than the presence of high-risk polyps. An analysis of data from 239,217 individuals found no significant association between high-risk polyps and PCCRC risk. Instead, higher adenoma detection rates (ADR) and proximal serrated polyp detection rates (PSPDR) correlated with […]